SCHEMBL18954631

SCHEMBL18954631

CCN1C(=O)C(=O)c2cc(F)c(Cl)cc21

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PARK7 Q99497 2/20 0.58
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ CA12 O43570 3/20 0.39
▸ CA1 P00915 3/20 0.39
▸ CA2 P00918 3/20 0.39
▸ CA9 Q16790 3/20 0.39
▸ ALDH1A1 P00352 3/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ APAF1 O14727 2/20 0.38
▸ ALDH2 P05091 1/20 0.37
▸ ALDH3A1 P30838 1/20 0.37
▸ BRD4 O60885 2/20 0.37
▸ CHRM5 P08912 2/20 0.36
▸ PIM1 P11309 1/20 0.36
▸ GSK3A P49840 1/20 0.36
▸ PIM3 Q86V86 1/20 0.36
▸ PIM2 Q9P1W9 1/20 0.36
▸ TP53 P04637 1/20 0.35
▸ CYP1A2 P05177 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28527361 0.83 CES1 (0.43) PARK7CA12CA1CA2CA9
SCHEMBL18954678 0.80 CASP3 (0.45) PARK7CA12CA1CA2CA9
SCHEMBL18954838 0.80 CUL4A (0.40) PARK7CA12CA1CA2CA9
SCHEMBL18954706 0.79 ALDH1A1 (0.43) PARK7ALDH1A1CHRM5MAPTCES1
SCHEMBL18954755 0.78 CASP3 (0.46) PARK7CA12CA1CA2CA9
SCHEMBL18954712 0.78 ALDH1A1 (0.47) PARK7ALDH1A1LMNAGSK3AMAPT
SCHEMBL18954538 0.76 ALDH1A1 (0.46) ALDH1A1LMNAMAPTTSHRHSD17B10
SCHEMBL10615889 0.74 PARK7 (0.50) PARK7
SCHEMBL4338990 0.74 PARK7 (0.50) PARK7CA1CA2ALDH1A1KDM4E
SCHEMBL20254404 0.73 PARK7 (1.00) PARK7CA12CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017099695-A1 N-[(AMINOSULFONYL)PHENYL]-2-(1,2-DIHYDRO-2-OXO-3H-INDOL-3-YLIDENE)-HYDRAZINECARBOTHIOAMIDE DERIVATIVES FOR TREATING CANCER AND IMMUNOLOGICAL DISORDERS ISTANBUL UNIVERSITESI REKTORLUGU (TR) 2017-06-15 — — WO disclosed
Send feedback